SecBot SecBot
SECBOTREPLAY Home › Report › CYTK

CYTK · CEO Robert Blum and EVP/Chief Commercial Officer Andrew Callos sold a…

CYTOKINETICS INC · CLUSTER filed Jul 30, 2026 at 16:26 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 30, 2026 at 16:26 ET

CEO Robert Blum and EVP/Chief Commercial Officer Andrew Callos sold a combined $1.72M in open-market shares over a 4-day window. The CEO sale ($607K) and CCO sale ($1.12M) are both cash exercises of options followed by immediate sales, a common pattern for tax/vesting liquidity. At a $9.8B market cap, the total open-market sales represent ~0.018% of market cap, well below the 0.1% materiality threshold. The cluster is not informative per the academic literature: both sales are liquidity-driven (option exercise + sell) rather than conviction-based, and cluster sells are not predictive of negative returns. The cross-filing actuarial verdicts are all amplifiers, but the underlying event is trivial in size and structure, so no override applies.

  • CEO Robert Blum sold 7,500 shares at $80.87 for $606,525 on 2026-07-27, following option exercises at $0 and $10.60 per share.
  • EVP/Chief Commercial Officer Andrew Callos sold 14,000 shares at $79.88 for $1,118,320 on 2026-07-30, following option exercises at $23.26 and $0 per share.
  • Total open-market sales of $1.72M represent ~0.018% of CYTK's $9.8B market cap, trivial and routine.
  • Both sales are cashless option exercise-and-sell patterns, consistent with tax/vesting liquidity rather than informed selling.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access